The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
12
4 drops applied daily for 150 days
Charlotte Eye, Ear, Nose & Throat Associates
Charlotte, North Carolina, United States
Mean change in intraocular pressure from baseline
Time frame: 150 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.